Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 10, 2026

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

Fit-for-purpose biomarker method validation in anticancer drug development.

Jeffrey Cummings1, Tim H Ward, Caroline Dive

  • 1Paterson Institute for Cancer Research, University of Manchester, England, United Kingdom. jcummings@picr.man.ac.uk

Drug Discovery Today
|August 17, 2010
PubMed
Summary

Biomarker method validation is crucial for new anticancer drugs. This review clarifies issues and offers guidance on fit-for-purpose validation strategies for biomarker assays in clinical trials.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Circadian genotypes in PER3 and time of prostate cancer radiotherapy interact to affect risk of late side-effects.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Cediranib with weekly paclitaxel or olaparib versus weekly paclitaxel for advanced or recurrent endometrial cancer (COPELIA): a multicentre, open-label, randomised, phase 2 trial in the UK.

EClinicalMedicine·2026
Same author

Advancing the applications of liquid biopsies in oncology.

Nature reviews. Genetics·2026
Same author

Use of circulating tumour DNA to prospectively guide a switch from targeted to immune therapy in BRAF mutant advanced melanoma: the randomised phase II CAcTUS trial.

Nature communications·2026
Same author

Racial and Ethnic Representation in Dementia Clinical Trials Registered on ClinicalTrials.gov in the United States, United Kingdom, and Canada.

International journal of geriatric psychiatry·2026
Same author

Alzheimer's Disease blood biomarkers measured through remote capillary sampling correlate with cognition in older adults.

Nature communications·2026

Area of Science:

  • Biomarker discovery and validation
  • Clinical trial methodology
  • Regulatory science

Background:

  • Biomarker qualification is essential for developing new anticancer drugs.
  • Method validation is a critical regulatory requirement for biomarker qualification.
  • The fit-for-purpose approach offers a flexible yet rigorous framework for biomarker method validation.

Purpose of the Study:

  • To clarify scientific and regulatory issues in biomarker method validation.
  • To provide guidance on analyzing samples from clinical trial subjects.
  • To offer validation strategies for different categories of biomarker assays.

Main Methods:

  • Literature review focusing on biomarker method validation.
  • Analysis of regulatory requirements and scientific challenges.

More Related Videos

Assessing Specificity of Anticancer Drugs In Vitro
09:39

Assessing Specificity of Anticancer Drugs In Vitro

Published on: March 23, 2016

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
07:40

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis

Published on: March 20, 2021

Related Experiment Videos

Last Updated: Jun 10, 2026

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

Assessing Specificity of Anticancer Drugs In Vitro
09:39

Assessing Specificity of Anticancer Drugs In Vitro

Published on: March 23, 2016

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
07:40

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis

Published on: March 20, 2021

  • Categorization of biomarker assays and corresponding validation approaches.

    • Main Results:

    • Identification of key challenges in biomarker method validation.
    • Explanation of the fit-for-purpose approach and its implications.
    • Development of specific guidance for five categories of biomarker assays.

    Conclusions:

    • Clearer understanding of biomarker method validation is needed.
    • The fit-for-purpose approach requires careful implementation.
    • Standardized validation strategies will enhance biomarker utility in drug development.